Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics. - Wikidata - wikimedia - TriplyDB

Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics.

Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics.

http://www.wikidata.org/entity/Q37990946

about

Heparin: Past, Present, and Future Polysulfated trehalose as a novel anticoagulant agent with dual mode of action.Preparation and application of a 'clickable' acceptor for enzymatic synthesis of heparin oligosaccharides Towards the chemoenzymatic synthesis of heparan sulfate oligosaccharides: Oxidative cleavage of p-nitrophenyl group with ceric ammonium salts.Effect of eliminase gene (elmA) deletion on heparosan production and shedding in Escherichia coli K5.New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism.Heparin-polynitroxide derivatives: a platform for new diagnostic and therapeutic agents in cardiovascular disease?Glycosaminoglycan-Based Biohybrid Hydrogels: A Sweet and Smart Choice for Multifunctional Biomaterials.Analysis of glycosaminoglycan-derived, precolumn, 2-aminoacridone-labeled disaccharides with LC-fluorescence and LC-MS detection.Heparin: role in protein purification and substitution with animal-component free material Enoxaparin prevents steroid-related avascular necrosis of the femoral head

P2860

Q26744227-8D26F1FF-094A-420B-8901-2E91611BA28B Q35239901-267A05E3-2B4A-4F71-9731-8172BB1E58AB Q36802319-FDEF67E9-A003-480D-B839-12F105EB54CD Q37069982-0F4B8981-9AD2-4C11-B51A-99CABBCE404E Q37694474-F12DC446-DDC2-4A44-832E-7E0D6855DC97 Q39213540-5993775E-D3CF-496A-97F6-B4E01951B350 Q39451157-02D8EC20-3352-407E-9BB2-2A3A8B2B08BE Q41628734-FF24EE2E-CFC9-40A7-814F-DBA783A0ECDB Q53625004-19BEB33C-1713-49E1-8BC5-5FEA9A55BEE9 Q58792047-923CAD4A-DB67-450D-A0C9-08CD6D4E3FDC Q59075527-90AF8F28-7430-4566-8BA5-DA25A6C38852

P2860

Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics.

http://www.wikidata.org/entity/Q37990946

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics.

@en

Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics.

@nl

type

label

Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics.

@en

Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics.

@nl

prefLabel

Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics.

@en

Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics.

@nl

P1433

Q37990946-891F6CC0-7C44-4C9D-830D-0A57C8185B61

P1476

Q37990946-BE47C308-4614-433B-87E1-841503BFA7A3

P2093

Q37990946-C87A8B8F-AE89-468D-852F-084524E53182

P2860

Q37990946-03D4D57F-2DC1-4EE6-9745-BAD63B70355A

Q37990946-07F886C2-1F7D-4B86-8963-FA81B4CE0A08

Q37990946-11B84726-3D26-4FD3-ABC9-65AA738E7C01

Q37990946-13159BE6-7560-42F3-9F25-3C86343237B2

Q37990946-161710B0-2CC8-424E-8AF9-9C35324BC504

Q37990946-1964ABE6-9994-448F-BA99-3EFE9A0EF5BB

Q37990946-1AE3B75D-B825-4672-A456-349953FC75E8

Q37990946-1D5A9F83-0931-4D15-926E-A04F3452F8DD

Q37990946-1E22656F-AB10-4509-B853-D11B570D5AA2

Q37990946-24BF15DC-8355-42EC-8BB8-A6585A46F3DC

P304

Q37990946-6C76FFF3-EA8A-4FC6-B19E-C90945840106

P31

Q37990946-A1A15FE9-5ED7-403B-A70F-34380BE29370

P356

Q37990946-E33BBB92-D30F-4B47-BEAC-9AA1974FA9F7

P433

Q37990946-108A9240-ABFD-4540-9197-382349ED0E9B

P478

Q37990946-65A3E47D-9A77-45CB-8615-B7410BD0F2BB

P50

Q37990946-0DD0D59A-150E-423A-B8E0-E3E59A0D81B3

P577

Q37990946-7B514868-0F03-4389-B335-EC2204F3A295

P5875

Q37990946-91E535A5-1DE3-45DE-99A0-88FA27958944

P698

Q37990946-29C9EBAC-BE5F-434F-B44A-006CEF5FDAA6

P932

Q37990946-C28C7F3F-2ADC-478C-B4FB-AEF899E93741

P356

P1433

Future Medicinal Chemistry

P1476

Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics.

@en

P2093

Sayaka Masuko

http://www.w3.org/2001/XMLSchema#string

P2860

The anticoagulant activation of antithrombin by heparin

Engineering of routes to heparin and related polysaccharides

Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement

Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials.

Complications of heparin therapy.

A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?

Heparin-induced thrombocytopenia: a historical perspective.

New parenteral anticoagulants in development.

Pharmacokinetic and pharmacodynamic properties of oral anticoagulants, especially phenprocoumon.

Chemoenzymatic design of heparan sulfate oligosaccharides

P304

289-296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC.11.185

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Robert J. Linhardt

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221680887

http://www.w3.org/2001/XMLSchema#string

P698

22393937

http://www.w3.org/2001/XMLSchema#string

P932

3320513

http://www.w3.org/2001/XMLSchema#string